Lapatinib in Treating Patients With Recurrent and/or Metastatic Adenoid Cystic Cancer or Other Salivary Gland Cancers
NCT00095563 · COMPLETED · phase2
High-grade Salivary Gland Carcinoma, High-grade Salivary Gland Mucoepidermoid Carcinoma, Low-grade Salivary Gland Carcinoma, Low-grade Salivary Gland Mucoepidermoid Carcinoma,...
ClinicalTrials.gov recordIressa Study in Patients With Salivary Gland Cancer
NCT00509002 · COMPLETED · phase2
Salivary Gland Cancer
ClinicalTrials.gov recordDasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors
NCT00859937 · COMPLETED · phase2
Malignant Salivary Gland Neoplasm, Recurrent Salivary Gland Carcinoma, Salivary Gland Adenoid Cystic Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v7
ClinicalTrials.gov recordVorinostat in Treating Patients With Locally Advanced, Recurrent, or Metastatic Adenoid Cystic Carcinoma
NCT01175980 · COMPLETED · phase2
Recurrent Oral Cavity Adenoid Cystic Carcinoma, Recurrent Salivary Gland Carcinoma, Salivary Gland Adenoid Cystic Carcinoma, Stage III Major Salivary Gland Cancer AJCC v7,...
ClinicalTrials.gov recordStereotactic Body Radiotherapy for Head and Neck Tumors
NCT01344356 · COMPLETED · phase4
Squamous Cell Carcinoma of the Head and Neck, Nasopharyngeal Carcinoma, Salivary Gland Cancer, Head and Neck Sarcoma, Paraganglioma of Head and Neck, Chordoma of Head and Neck,...
ClinicalTrials.gov recordAkt Inhibitor MK2206 in Treating Patients With Progressive, Recurrent, or Metastatic Adenoid Cyst Carcinoma
NCT01604772 · COMPLETED · phase2
Recurrent Oral Cavity Adenoid Cystic Carcinoma, Recurrent Salivary Gland Carcinoma, Salivary Gland Adenoid Cystic Carcinoma, Stage IVA Major Salivary Gland Cancer AJCC v7,...
ClinicalTrials.gov recordEribulin Mesylate in Treating Patients With Recurrent or Metastatic Salivary Gland Cancer
NCT01613768 · COMPLETED · phase2
Recurrent Salivary Gland Cancer, Stage IVA Salivary Gland Cancer, Stage IVB Salivary Gland Cancer, Stage IVC Salivary Gland Cancer
ClinicalTrials.gov recordEnzalutamide for Patients With Androgen Receptor Positive Salivary Cancers
NCT02749903 · ACTIVE NOT RECRUITING · phase2
Androgen Receptor Positive, Locally Advanced Salivary Gland Carcinoma, Metastatic Salivary Gland Carcinoma, Salivary Duct Carcinoma, Salivary Gland Adenocarcinoma, NOS,...
ClinicalTrials.gov recordNivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer
NCT03146650 · UNKNOWN · phase2
Major Salivary Gland Carcinoma, Minor Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Carcinoma, Stage IVA Major Salivary Gland...
ClinicalTrials.gov recordStudy of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer
NCT03172624 · COMPLETED · phase2
Salivary Gland Cancer
ClinicalTrials.gov recordNivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers
NCT03749460 · COMPLETED · phase1, phase2
Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Lung, Salivary Gland Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v8, Stage IVA Major...
ClinicalTrials.gov recordA Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma
NCT04325828 · ACTIVE NOT RECRUITING · phase2
Salivary Gland Neoplasms
ClinicalTrials.gov recordA Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations
NCT04639219 · ACTIVE NOT RECRUITING · phase2
Advanced Solid Tumors With HER2 Mutation,eg:Colorectal,Urothelial,Gastric, Hepatobiliary,Endometrial,Melanoma,Ovarian,Cervical,Salivary Gland,Pancreatic,Breast
ClinicalTrials.gov recordMC200708 Pemetrexed and Pembrolizumab for the Treatment of Recurrent and/or Metastatic Salivary Gland Cancer
NCT04895735 · ACTIVE NOT RECRUITING · phase2
Metastatic Salivary Gland Carcinoma, Recurrent Salivary Gland Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v8, Adenoid Cystic Carcinoma
ClinicalTrials.gov record9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma
NCT05010629 · ACTIVE NOT RECRUITING · phase2
Salivary Gland Cancer, Recurrent Salivary Gland Cancer, Metastatic Cancer, Adenoid Cystic Carcinoma
ClinicalTrials.gov recordAmivantamab in Adenoid Cystic Carcinoma
NCT05074940 · ACTIVE NOT RECRUITING · phase2
Salivary Gland Cancer
ClinicalTrials.gov record